Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q4 2013 (← Previous) (Next →)

Filing Date: Feb 14, 2014

Total Value: $199M (100.0% shares, 0.0% debt)

Holdings (14)

— Medivation, Inc. 79.8%

Value $159M Shares 2,484,101 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 7.3%

Value $14.45M Shares 2,026,998 Est. Cost $6.38 Unrealized —

— Alcobra Ltd 6.2%

Value $12.37M Shares 687,000 Est. Cost $8.47 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.3%

Value $2.592M Shares 200,000 Est. Cost $10.21 Unrealized —

— Sequenom Inc. 1.0%

Value $2.073M Shares 893,600 Est. Cost $4.21 Unrealized —

— Synthetic Biologics Inc. 1.0%

Value $2.054M Shares 1,360,000 Est. Cost $1.51 Unrealized —

— Newlink Genetics Corp 0.9%

Value $1.704M Shares 77,437 Est. Cost $19.35 Unrealized —

— Inovio Pharmaceuticals Inc. 0.6%

Value $1.167M Shares 408,352 Est. Cost $2.86 Unrealized —

— Vivus Inc. 0.5%

Value $1.05M Shares 5,000 Est. Cost — Unrealized —

— Advaxis Inc. 0.5%

Value $947K Shares 225,000 Est. Cost $4.21 Unrealized —

— Parkervision Inc. 0.5%

Value $910K Shares 200,000 Est. Cost $4.55 Unrealized —

— Merrimack Pharmaceuticals Inc. 0.2%

Value $400K Shares 75,000 Est. Cost $5.33 Unrealized —

— Advaxis Inc. 0.1%

Value $186K Shares 112,500 Est. Cost $1.65 Unrealized —

— Echo Therapeutics Inc. 0.1%

Value $140K Shares 44,445 Est. Cost $0.25 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,484,101	$159M	79.8%	$49.20	—	Com	58501N101
—	Ampio Pharmaceuticals Inc.	2,026,998	$14.45M	7.3%	$6.38	—	Com	03209T109
—	Alcobra Ltd	687,000	$12.37M	6.2%	$8.47	—	SHS	M2239P109
—	Keryx Biopharmaceuticals Inc.	200,000	$2.592M	1.3%	$10.21	—	Com	492515101
—	Sequenom Inc.	893,600	$2.073M	1.0%	$4.21	—	Com New	817337405
—	Synthetic Biologics Inc.	1,360,000	$2.054M	1.0%	$1.51	—	COM	87164U102
—	Newlink Genetics Corp	77,437	$1.704M	0.9%	$19.35	—	Com	651511107
—	Inovio Pharmaceuticals Inc.	408,352	$1.167M	0.6%	$2.86	—	CPM	45773H102
—	Vivus Inc.	5,000	$1.05M	0.5%	—	—	Call	928551900
—	Advaxis Inc.	225,000	$947K	0.5%	$4.21	—	COM NEW	7624208
—	Parkervision Inc.	200,000	$910K	0.5%	$4.55	—	COM	701354102
—	Merrimack Pharmaceuticals Inc.	75,000	$400K	0.2%	$5.33	—	COM	590328100
—	Advaxis Inc.	112,500	$186K	0.1%	$1.65	—	W EXP 07/15/201	7624117
—	Echo Therapeutics Inc.	44,445	$140K	0.1%	$0.25	—	Com New	27876L206